LMRI · Lumexa Imaging Holdings, Inc.
$11.66
+7.07% last session
End-of-day data · close of 2026-10-23
Market cap
$1B
Enterprise value
$2B
Trailing P/E
—
Forward P/E
13.1
Dividend yield
0.0%
Beta
—
Avg volume
0M
Employees
5K
Daily Change %
7.07%
5 Days Change
1.02%
10 Days Change
2.64%
30 Days Change
7.40%
60 Days Change
-8.10%
Month to Day Change
7.82%
Year to Day Change
-41.14%
Analyst Outlook
Analyst estimates change daily — follow the shifts on the Estimate Trends page.
Technical Analysis
Analyst sentiment over time — LMRI
Rec Mean (blue, left — higher = more bullish) vs. price targets (right).
Investment Bank Ratings as of 2026-10-05
Latest call per bank · past 12 months
Barclays
Overweight$13.00
+11.5% vs priceWells Fargo
Overweight$22.00
+88.7% vs priceDeutsche Bank
Buy$22.00
+88.7% vs priceJefferies
Buy$23.00
+97.3% vs priceRecent rating actions
| Date | Firm | Action | Rating | Price target |
|---|---|---|---|---|
| 2026-10-05 | Truist Securities | Initiates | Buy | $0.00 → $18.00 |
| 2026-09-25 | Keybanc | Initiates | Overweight | $0.00 → $18.00 |
| 2026-08-28 | Barclays | Maintains | Overweight | $9.00 → $13.00 |
| 2026-05-20 | Barclays | Maintains | Overweight | $15.00 → $9.00 |
| 2026-04-14 | Barclays | Maintains | Overweight | $23.00 → $15.00 |
| 2026-02-09 | Raymond James | Upgrade | Outperform → Strong Buy | $0.00 → $23.00 |
| 2026-01-05 | Raymond James | Initiates | Outperform | $0.00 → $23.00 |
| 2026-01-05 | Barclays | Initiates | Overweight | $0.00 → $23.00 |
Ratings and price targets are the published opinions of the issuing banks, compiled from Yahoo Finance rating actions — not investment advice.
Signal Summary as of 2026-10-23
- neutral: RSI (14): RSI is 66 — neutral momentum, neither overbought nor oversold.
- bullish: Price vs 50-day MA: Trading 4.8% above the 50-day MA ($11.13).
- bullish: Price vs 200-day MA: Trading 3.9% above the 200-day MA ($11.22).
- bearish: MA cross: The 50-day MA sits below the 200-day MA (death-cross regime) — the longer-term trend points down.
- bullish: MACD (12,26,9): MACD histogram is positive (+0.12) — short-term momentum is improving.
- neutral: 52-week range: Price sits between the 52-week low ($6.77) and high ($18.53).
LMRI Price Chart
Loading chart for LMRI…
Fundamentals
About Lumexa Imaging Holdings, Inc.
Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.
More in Medical Devices
ABT
Abbott Laboratories
$179B -16.2% YTD
MDT
Medtronic plc.
$122B 3.1% YTD
SYK
Stryker Corporation
$118B -11.9% YTD
BSX
Boston Scientific Corporation
$66B -51.7% YTD
EW
Edwards Lifesciences Corporatio
$51B 5.7% YTD
GEHC
GE HealthCare Technologies Inc.
$33B -12.8% YTD
DXCM
DexCom, Inc.
$29B 18.0% YTD
PHG
Koninklijke Philips N.V. NY Reg
$26B 3.3% YTD
Data is sourced from end-of-day snapshots and refreshed daily before the US market open — nothing on this page is real-time. Figures can contain vendor errors. This page is for information only and is not investment advice.